Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rasagiline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chiral auxiliary method for rasagiline production offering high yield and reduced pollution for pharmaceutical manufacturers seeking reliable supply chains.
Patent CN101062897B details a novel Al-Ni alloy reduction for 2,3-dihydro-1H-inden-1-amine. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN102464589A details a high-yield route for Rasagiline mesylate using chiral aminolysis and alkylation, offering significant cost reduction in API manufacturing.
Novel trifluoroacetyl protection route for high-purity rasagiline. Reduces waste, avoids resolution, ensures supply continuity for Parkinson's API manufacturing.
Patent CN110776429A details a high-yield one-pot synthesis for Rasagiline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.